Stocks-ABBV-AbbVie Inc

ABBV AbbVie Inc

173.29 0 (0%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2023: AbbVie Inc's revenues decreased by 6.44% and amounted to 54.32B. Net income decreased by 58.92% to 4.87B. Net assets decreased by NaN to N/A and EPS decreased from 6.66 to 2.74.
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
Net Profit Margin
Operating Margin
Return On Investment